The purpose of this study is to determine whether intracoronary injection of morphine chlorhydrate is effective to limit ischemia-reperfusion lesion during percutaneous coronary angioplasty in patients with acute myocardial infarction (AMI).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
94
1mg of morphine chlorhydrate dilute in 3ml of saline solution, intracoronary injection, just before reperfusion
3 ml of saline solution , intracoronary injection during reperfusion
Henri Mondor Hospital
Créteil, France
Hopital Marie Lannelongue
Le Plessis-Robinson, France
Infarct size evaluated by delayed enhancement-magnetic resonance imaging
Time frame: between day 3 and day 5 after acute myocardial infarction (AMI)
Infarct size/area at risk ratio evaluated by MRI
Time frame: between day 3 and day 5 after AMI
release of creatine kinase (CK) and troponin I (TnI) during reperfusion
The Area Under the Curve of CK and TnI during reperfusion
Time frame: during the first 72 hours after reperfusion
the Thrombolysis In Myocardial Infarction (TIMI) myocardial Blush after reperfusion
Time frame: at day 0
ST segment resolution after reperfusion
Time frame: during the first 24 hours after reperfusion
Left Ventricular Ejection Fraction measured by echocardiography
Time frame: at day 1 and day 6
Infarct size measurement by delayed enhancement-magnetic resonance imaging
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.